Elyse N. Burgess

Ms. Elyse N. Burgess

Medicine, Baylor College of Medicine, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Cancer
Verified
Journal Article
Closed access
THThanh T. Hoang
Thanh T. Hoang
RRRutu A. Rathod
Rutu A. Rathod
OROmar Rosales
Omar Rosales
MCMaria I. Castellanos
Maria I. Castellanos
JSJeremy M. Schraw
Jeremy M. Schraw
EBElyse N. Burgess
Elyse N. Burgess

24 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
ISItunu Sokale
Itunu Sokale
OROmar Rosales
Omar Rosales
ATAaron P. Thrift
Aaron P. Thrift
HEHashem El-Serag
Hashem El-Serag
EBElyse N. Burgess
Elyse N. Burgess
AOAbiodun O Oluyomi
Abiodun O Oluyomi
Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer diagnoses and deaths in the United States. This study serves as an update on secular trends in national HCC incidence rates while exploring potential geographic and racial/ethnic differences across all nine US census divisions. Methods: We analyzed HCC incidence data reported to the United States Cancer Statistics (USCS) database from 2001 to 2021 (excluding 2020 data, based on the Centers for Disease Control and Prevention’s cautionary recommendations for COVID-19 pandemic data usage for trend analysis). We performed trend analyses of age-adjusted incidence rates in the US overall, by census divisions, and then stratified by race/ethnicity, using the National Cancer Institute’s Joinpoint Regression Program. Results: Between 2001 and 2021, HCC incidence rates increased nationally, with an average annual percentage change (AAPC) of 2.51 (95% confidence interval (CI): 2.32–2.72); however, the rate decreased (annual percentage change (APC) −3.33 (95% CI: −4.78–−1.96) in recent years from 2018 to 2021. Division 1 had the greatest decrease (APC −6.46 (95% CI: −9.62–−3.96) from 2017 to 2021, while rates leveled in Division 6 (East South Central) and Division 7 (West South Central). HCC trends decreased substantially for non-Hispanic Black and Non-Hispanic Asian and Pacific Islander groups in almost all divisions in recent years, but trends were stable, decreased, or increased for other racial/ethnic populations. Conclusions: Despite declining national HCC incidence rates, these trends were not uniform across racial/ethnic groups or US census divisions. Race-specific interventions are needed to reduce disparities in HCC incidence in all US census divisions.